BRIEF published on 05/08/2024 at 11:10, 6 months 13 days ago GESCO SE Concludes Share Buyback Program Shareholder Value Share Buyback Corporate Finance GESCO SE Prime Standard
PRESS RELEASE published on 05/08/2024 at 11:05, 6 months 13 days ago GESCO SE announces result of the share buyback programme GESCO SE successfully completes share buyback program with a repartition rate of 94.9% and currently holds 4.72% treasury shares. Details on possible uses available on company website Share Buyback Investor Relations Treasury Shares GESCO SE Repurchased Shares
BRIEF published on 04/11/2024 at 07:35, 7 months 10 days ago GESCO SE Announces Positive Financial Results and Optimistic Outlook for 2024 Financial Results 2024 Outlook Share Buyback Program Dividend Announcement GESCO SE
PRESS RELEASE published on 04/11/2024 at 07:30, 7 months 10 days ago GESCO SE: Publication of consolidated financial statements & outlook for 2024 GESCO SE publishes 2023 Annual Report and forecasts sales of €570-590 million and net earnings of €26-28 million for 2024. Share buyback programme initiated Share Buyback Programme 2023 Annual Report Sales Forecast GESCO SE Net Earnings Forecast
BRIEF published on 04/08/2024 at 16:05, 7 months 12 days ago GESCO SE Announces Johannes Pfeffer as New CEO CEO Appointment Leadership Transition Industrial Sector GESCO SE Johannes Pfeffer
PRESS RELEASE published on 04/08/2024 at 16:00, 7 months 12 days ago EQS-Adhoc: GESCO SE: Johannes Pfeffer appointed new CEO GESCO SE appoints Johannes Pfeffer as new CEO, succeeding Ralph Rumberg. Pfeffer, with a background in physics and an MBA, will take over on 1 October 2024. Company transition praised by Stefan Heimöller CEO Appointment GESCO SE Johannes Pfeffer Transition Process Stefan Heimöller
BRIEF published on 03/28/2024 at 17:37, 7 months 23 days ago GESCO SE Announces Public Share Buyback Offer Share Buyback Investor Relations Treasury Shares Public Offer GESCO SE
PRESS RELEASE published on 03/28/2024 at 17:32, 7 months 23 days ago EQS-Adhoc: GESCO SE submits public share buyback offer GESCO SE to buy back up to 500,000 registered shares at EUR 17.80 per share through a public offer. Offering period: 11-25 April 2024. Details on company website and Federal Gazette Share Buyback Investor Relations Treasury Shares Public Offer GESCO SE
BRIEF published on 03/20/2024 at 15:58, 8 months ago GESCO SE Announces Dividend Proposal Following Steady Fiscal Year Performance Annual General Meeting Financial Performance Earnings Report Dividend Proposal GESCO SE
PRESS RELEASE published on 03/20/2024 at 15:53, 8 months ago EQS-Adhoc: GESCO SE publishes dividend proposal GESCO SE reports meeting forecast with Group sales of €560.7 million and proposes a dividend of €0.40 per share for 2023. Annual General Meeting scheduled for 29 May 2024 Financial Results Annual General Meeting Dividend Proposal Forecast GESCO SE
Published on 11/21/2024 at 13:30, 19 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 19 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 49 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 49 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 49 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 14 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 34 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 51 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 29 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo